1. How does CBD differ from THC?
A. CBD has a lower abuse potential than THC
B. CBD is more effective than THC for more conditions
C. CBD is produced in different plants than THC
D. CBD is a metabolite of THC
2. The therapeutic effects of Epidiolex are due to:
A. Acting as an agonist of CB1 receptors
B. Acting as an antagonist of CB1 receptors
C. Acting on neurotransmitter receptors other than cannabinoid receptors
D. Blocking voltage-gated sodium channels
3. The FDA approved form of CBD has been approved for the treatment of:
A. Anxiety
B. Pain
C. Rare pediatric seizures
D. Cancer
4. Which of the following is INCORRECT regarding Epidiolex?
A. It is a purified extract of CBD from marijuana plants
B. It is the first marijuana-based product approved by the FDA
C. It is currently only available from available from certain specialty pharmacies
D. A side effect found during clinical trials is elevation of liver enzymes and possible liver injury
5. The DEA placed Epidiolex in which schedule?
A. C-II
B. C-III
C. C-V
D. It was not scheduled as a controlled substance
6. How is CBD regulated under state laws?
A. CBD is considered the same as “marijuana” in all states
B. CBD has been approved for use in all 50 states
C. CBD is legal only in the states that have approved recreational marijuana
D. CBD is legal under state law where there is a medical marijuana program as well as some states that do not have a general medical marijuana law
7. Hemp is legally defined as:
A. A marijuana plant which produces more CBD than THC
B. A marijuana plant which does not produce THC
C. A marijuana plant with a THC content not exceeding 0.3%
D. A CBD producing plant that is not a member of the Cannabis species
8. What effect did the 2018 Farm Bill have on the legal status of CBD?
A. It became legal to grow plants which produce CBD
B. It removed hemp from the definition of marijuana
C. It approved the introduction of CBD in food
D. It permits hemp to be sold as a drug
9. The FDA's position on marketing CBD as a dietary supplement is:
A. This is permissible because it is a natural plant product
B. This is not permissible because CBD had previously been approved as a “drug”
C. This is not permissible because there are concerns about the safety of CBD
D. This is not permissible because it has previously been considered a controlled substance
10. The FDA's and FTC's concerns about CBD include the following EXCEPT:
A. Poor quality control by many manufacturers
B. Unsubstantiated claims of therapeutic efficacy
C. Potential side effects
D. The lack of pharmacist oversight
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20